Rockefeller Capital Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
Rockefeller Capital Management's HRMY Position: Q3 2026 in Review
Rockefeller Capital Management reduced its Harmony Biosciences (HRMY) stake by 0.66% in Q3 2026, selling an estimated $3.01K and leaving 11,728 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #2172.
Rockefeller Capital Management first reported a position in HRMY in Q2 2022 and has held it in 8 quarters since. The position peaked at $665K in Q4 2025. 358 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.
- Rockefeller Capital Management held 11,728 shares of Harmony Biosciences worth $460K as of Q3 2026.
- Rockefeller Capital Management sold 78 Harmony Biosciences shares in Q3 2026, an estimated $3.01K.
- Harmony Biosciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #2172 holding.
- Rockefeller Capital Management first reported a position in Harmony Biosciences in Q2 2022 and has held it in 8 quarters since.
- Rockefeller Capital Management's Harmony Biosciences position peaked at $665K in Q4 2025.
- 358 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.